17 Mar Press Release Scilex Holding Company, a Majority-owned Subsidiary OF Sorrento Therapeutics, Inc., to Become Publicly Traded Through a Merger With Vickers Vantage Corp. I March 17, 2022 Posted by Ulisses • Combined company expected to have a pro forma equity value post-money of approximately $1.64 billion, subject to potential adjustment, and with up to $140 million in expected gross proceeds before...Read more
24 Feb SEC FIlings Annual report for fiscal year ending Dec 31, 2021 November 17, 2022 Posted by Ulisses Read more
18 Feb SEC FIlings Prospectuses and communications, business combinations November 17, 2022 Posted by Ulisses Read more
14 Feb SEC FIlings Statement of acquisition of beneficial ownership by individuals – Amendment November 17, 2022 Posted by Ulisses Read more
11 Feb SEC FIlings Statement of acquisition of beneficial ownership by individuals November 17, 2022 Posted by Ulisses Read more
03 Feb SEC FIlings Statement of acquisition of beneficial ownership by individuals November 17, 2022 Posted by Ulisses Read more
02 Feb SEC FIlings Statement of acquisition of beneficial ownership by individuals – Amendment November 17, 2022 Posted by Ulisses Read more
10 Jan SEC FIlings Statement of acquisition of beneficial ownership by individuals November 17, 2022 Posted by Ulisses Read more